Go Top

臺北市立聯合醫院臨床試驗中心Taipei City Hospital Center for Clinical Trials

  • Total Beds3,078
  • Total Doctors850
  • AddressNo.145, Zhengzhou Rd.,Datong,Taipei City 103

1. The merger of ten Taipei municipal hospitals into one unit has made the Taipei City Hospital a large healthcare institutein Northern Taiwan. The purpose of this merger was not only to improve hospital-and community- based healthcare, but also to rebuild Taipei City’s entire public healthcare system. The theme of this reform was the creation of a “Wholistic Care System”.

2. Taipei City Hospital has a total of 7 branches, which are located in various administrative districts of Taipei City. The supply of hospital beds is sufficient, and the resources of each institution are shared among seven branches and thus the research efficacy could be enhanced.

3. Our hospital is committed to Home care, Palliative care, Long-term care, and Integrated dementia care, and so is capable of developing clinical trials of related medical devices.

Site Introduction

The Centre of Clinical Trials (CCT) in Department of Education and Research in Taipei City Hospital (TPECH) was launched in 2009 and the relevant facilities werefounded in 2010. It is located at the 8th floor of the main building in Ren-ai Branch. We aim to encourage investigators in TPECH to translate their biological discoveries into clinical settings i.e. to realize improving human health through science. We design a series of training programs to help professionals to gain a solid understanding of the entire clinical trials process – from development of a new medication and device to monitoring and surveillance of post marketing activities. The key feature of these training initiatives is to ensure that the clinical investigators are well grounded in protocol design, research process, data management and analysis along with understanding of records confidentiality and research subjects protection. Subjects’ rights should always be the top priority in clinical trials. All protocols for clinical trials must be reviewed by REC, the Institutional Review Board, in TPECH. For new medications and devices, the approval from Food and Drug Administration in Taiwan (TFDA) is alsomandatory.

Our center is devoted to partnering with principal investigator (PI), industry and other research organizations. We provide consulting services (including pre-contract review, budget planning, and anything relevant to the trial) for both PI and sponsor. We hope that the administrative processing of the trial can be performed as soon as possible with our help.

Clinicl Trial Expertise

Psychiatry、Gastroenterology、Ophthalmology、Allergy, Immunology and Rheumatology、Infectious Diseases (Human Immunodeficiency Virus (HIV) Infection)、Endocrinology & Metabolism、Chest Medicine.

International Accreditation

GCP Inspection/audit

What types of clinical trial do you conduct?



Our hospital is committed to Home care, Palliative care, Long-term care, and Integrated dementia care, and so is capable of developing clinical trials of related medical devices.




Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial(2020)


A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-sixyear-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration(2019)


Lurasidone in the treatment of schizophrenia: Results of a double‐blind, placebo‐controlled trial in Asian patients(2019)


Stepwise Intensification of Prandial Insulin in Taiwanese Patients with T2DM. Final Analysis Report of the SPIRIT Study(2018)


Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study(2018)


Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study(2018)


A Randomized, Double-Blind Clinical Study on Blood Pressure Reduction and Blood Lipid Profile Amelioration on Treatment with ANKASCIN 568(2017)